Lawrence P. Wennogle - Net Worth and Insider Trading
Lawrence P. Wennogle Net Worth
The estimated net worth of Lawrence P. Wennogle is at least $12 Million dollars as of 2024-11-12. Lawrence P. Wennogle is the Vice President, Drug Discovery of Intra-Cellular Therapies Inc and owns about 126,500 shares of Intra-Cellular Therapies Inc (ITCI) stock worth over $12 Million. Details can be seen in Lawrence P. Wennogle's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Lawrence P. Wennogle has not made any transactions after 2015-06-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Lawrence P. Wennogle
Lawrence P. Wennogle Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Lawrence P. Wennogle owns 1 companies in total, including Intra-Cellular Therapies Inc (ITCI) .
Click here to see the complete history of Lawrence P. Wennogle’s form 4 insider trades.
Insider Ownership Summary of Lawrence P. Wennogle
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ITCI | Intra-Cellular Therapies Inc | 2015-06-08 | Vice President & Drug Discovery |
Lawrence P. Wennogle Latest Holdings Summary
Lawrence P. Wennogle currently owns a total of 1 stock. Lawrence P. Wennogle owns 126,500 shares of Intra-Cellular Therapies Inc (ITCI) as of June 8, 2015, with a value of $12 Million.
Latest Holdings of Lawrence P. Wennogle
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ITCI | Intra-Cellular Therapies Inc | 2015-06-08 | 126,500 | 91.57 | 11,583,605 |
Holding Weightings of Lawrence P. Wennogle
Lawrence P. Wennogle Form 4 Trading Tracker
According to the SEC Form 4 filings, Lawrence P. Wennogle has made a total of 0 transactions in Intra-Cellular Therapies Inc (ITCI) over the past 5 years. The most-recent trade in Intra-Cellular Therapies Inc is the sale of 25,000 shares on June 8, 2015, which brought Lawrence P. Wennogle around $671,000.
Insider Trading History of Lawrence P. Wennogle
- 1
Lawrence P. Wennogle Trading Performance
Lawrence P. Wennogle Ownership Network
Ownership Network List of Lawrence P. Wennogle
Ownership Network Relation of Lawrence P. Wennogle
Lawrence P. Wennogle Owned Company Details
What does Intra-Cellular Therapies Inc do?
Who are the key executives at Intra-Cellular Therapies Inc?
Lawrence P. Wennogle is the Vice President & Drug Discovery of Intra-Cellular Therapies Inc. Other key executives at Intra-Cellular Therapies Inc include director & Chairman & President & CEO Sharon Mates , EVP & Chief Commercial Officer Mark Neumann , and Chief Medical Officer Suresh K. Durgam .
Intra-Cellular Therapies Inc (ITCI) Insider Trades Summary
Over the past 18 months, Lawrence P. Wennogle made no insider transaction in Intra-Cellular Therapies Inc (ITCI). Other recent insider transactions involving Intra-Cellular Therapies Inc (ITCI) include a net sale of 696,112 shares made by Sharon Mates , a net sale of 156,651 shares made by Mark Neumann , and a net sale of 105,827 shares made by Suresh K. Durgam .
In summary, during the past 3 months, insiders sold 305,712 shares of Intra-Cellular Therapies Inc (ITCI) in total and bought 0 shares, with a net sale of 305,712 shares. During the past 18 months, 1,299,251 shares of Intra-Cellular Therapies Inc (ITCI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,299,251 shares.
Intra-Cellular Therapies Inc (ITCI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Intra-Cellular Therapies Inc Insider Transactions
Lawrence P. Wennogle Mailing Address
Above is the net worth, insider trading, and ownership report for Lawrence P. Wennogle. You might contact Lawrence P. Wennogle via mailing address: C/o Intra-cellular Therapies, Inc., 3960 Broadway, New York Ny 10032.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
